Order Article Reprints

Dohn LH, Thind P, Salling L, Lindberg H, Oersted S, Christensen IJ, Laerum OD, Illemann M, von der Maase H, Høyer-Hansen G, et al. Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder. Cancers. 2021; 13(10):2377. https://doi.org/10.3390/cancers13102377

Dohn, Line H., Peter Thind, Lisbeth Salling, Henriette Lindberg, Sofie Oersted, Ib J. Christensen, Ole D. Laerum, Martin Illemann, Hans von der Maase, Gunilla Høyer-Hansen, and et al. 2021. "Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder" Cancers 13, no. 10: 2377. https://doi.org/10.3390/cancers13102377

Dohn, L. H., Thind, P., Salling, L., Lindberg, H., Oersted, S., Christensen, I. J., Laerum, O. D., Illemann, M., von der Maase, H., Høyer-Hansen, G., & Pappot, H. (2021). Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder. Cancers, 13(10), 2377. https://doi.org/10.3390/cancers13102377